Results 101 to 110 of about 14,385 (213)
Summary Over the past decade, there has been a substantial increase in the diversity and number of therapeutic options for myeloproliferative neoplasms (MPNs). While many remain within the clinical trial arena, the clinician and patient community have seen more approvals reaching the clinic and a rethink on how best we should be approaching these ...
Trung Q. Ngo +3 more
wiley +1 more source
CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia
Treatment of relapsed or refractory acute myeloid leukaemia (AML) has remained a significant challenge, with limited available targeted immunotherapies.
Dreyzin, Alexandra +2 more
core +1 more source
Example of the gating strategy for monocytes- LiveDead Aqua (LDA)-/CD1c-/CD19-/CD36+/CD123-/CD303-.
Example of the gating strategy for monocytes- LiveDead Aqua (LDA)-/CD1c-/CD19-/CD36+/CD123-/CD303-.
Daniel H. Libraty (110206) +6 more
core +1 more source
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia
Monoclonal antibodies are being considered as biopharmaceuticals for the in vivo targeting of acute myeloid leukemia. Here we describe the generation and characterization of a fully-human monoclonal antibody specific to CD123, a surface marker which is ...
Manz, Markus G +6 more
core +2 more sources
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes
BACKGROUND AND OBJECTIVES: CD123 is an antibody that identifies the a chain of the human interleukin-3 receptor and is expressed in a variety of normal hematopoietic cells, acute leukemia and hairy cell leukemia (HCL).
I Del Giudice +9 more
doaj
Introduction: CD123 is a component of the IL-3 receptor expressed in several hematological malignancies including AML, ALL, HCL, and MDS. CD123 is a compelling target in AML due to its overexpression on AML blasts as well as leukemic stem cells, which ...
Rebecca Gottschalk +22 more
core +1 more source
CD123 monoclonal antibody in myelodysplastic syndrome
De Salvo, Luigi +11 more
openaire +2 more sources
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 919-920, October 2026.
Afshin Shameli, Russell K. Dorer
wiley +1 more source
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells
International audienceAbstract Chimeric antigen receptor (CAR) T cells express an extracellular domain consisting of a single-chain fragment variable (scFv) targeting a surface tumor-associated antigen. scFv selection should involve safety profiling with
Anna, François +23 more
core +1 more source

